These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15061016)

  • 1. [How to improve screening of Down syndrome].
    Ryynänen M; Tekay A; Niemimaa M; Taipale P; Heinonen S
    Duodecim; 2004; 120(3):354-5; author reply 355-6. PubMed ID: 15061016
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prenatal diagnosis of Down syndrome].
    Vimpeli T; Kuukankorpi A
    Duodecim; 2004; 120(3):353-4; author reply 355-6. PubMed ID: 15061015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Failure to screen Down syndrome].
    Metsälä T
    Duodecim; 2004; 120(3):352; author reply 355-6. PubMed ID: 15061014
    [No Abstract]   [Full Text] [Related]  

  • 4. [New rules for prenatal screening for T21: collateral damages].
    Grangé G
    Gynecol Obstet Fertil; 2010 Jan; 38(1):4-5. PubMed ID: 20022540
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
    Jaques AM; Halliday JL; Francis I; Bonacquisto L; Forbes R; Cronin A; Sheffield LJ
    BJOG; 2007 Jul; 114(7):812-8. PubMed ID: 17501960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting partial screening results: is it confusing and unsatisfactory?
    Mulvey S; Wallace EM
    Prenat Diagn; 2002 Jul; 22(7):633; author reply 633-4. PubMed ID: 12124702
    [No Abstract]   [Full Text] [Related]  

  • 9. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Malone FD
    Obstet Gynecol; 2005 Feb; 105(2):438; author reply 438-9. PubMed ID: 15684179
    [No Abstract]   [Full Text] [Related]  

  • 11. [Systematic proposal and obligation of information in Down syndrome screening].
    Grangé G; Azria E
    J Gynecol Obstet Biol Reprod (Paris); 2008 Oct; 37(6):535-7. PubMed ID: 18760548
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quality control of prenatal screening].
    Pihl K; Larsen T; Jønsson L; Hougaard D; Krebs L; Nørgaard-Pedersen B; Christiansen M
    Ugeskr Laeger; 2008 Aug; 170(35):2691-5. PubMed ID: 18761859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down syndrome screening: determining the cutoff level of risk for invasive testing.
    Schielen PC; Wildschut HI; Loeber JG
    Prenat Diagn; 2009 Feb; 29(2):190-2. PubMed ID: 19180631
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists.
    Cleary-Goldman J; Morgan MA; Malone FD; Robinson JN; D'Alton ME; Schulkin J
    Obstet Gynecol; 2006 Jan; 107(1):11-7. PubMed ID: 16394034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of standardization in determining gestational age for prenatal screening.
    Koster MP; Van Leeuwen-Spruijt M; Wortelboer EJ; Stoutenbeek P; Elvers LH; Loeber JG; Visser GH; Schielen PC
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):607-11. PubMed ID: 18720453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the current dilemma of Down syndrome screening.
    Rose NC
    Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing.
    Sharma G; McCullough LB; Chervenak FA
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):99-104. PubMed ID: 17299736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester combined screening for Down syndrome and other fetal anomalies.
    O'Leary P; Breheny N; Dickinson JE; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland.
    Valinen Y; Rapakko K; Kokkonen H; Laitinen P; Tekay A; Ahola T; Ryynanen M
    Am J Obstet Gynecol; 2007 Mar; 196(3):278.e1-5. PubMed ID: 17346554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for Down syndrome in the older woman: a risky business?
    Hodges RJ; Wallace EM
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):486-8. PubMed ID: 16401213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.